1-2 of 2
Silvia López
Close
Sort by
Journal Articles

How Are Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (MDS) Treated? Impact on Clinical Evolution and Overall Survival: A Report from the Erasme Study

Julia Montoro, MD, Helena Pomares, MD, Itziar Oiartzabal, MD, Teresa Bernal, MD, Edgardo Barranco, MD, Rosa Coll, MD, Rafael Romero, MD, Marisa Calabuig, MD, Eduardo Salido, MD PhD, Marta Castellanos, MD, Angeles Medina, MD, Gemma Azaceta, MD PhD, Mireya Navarro, MD, Silvia López, David Valcárcel, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5239.
https://doi.org/10.1182/blood.V126.23.5239.5239
Published: 2015
Journal Articles

Validation Of a Comprehensive Health Status Assessment Scale In Older Patients (≥ 65 years) With Hematological Malignances. Gah Study

Santiago Bonanad, MD, Ernesto Perez Persona, MD, Itziar Oiartzabal, MD, Bernardo Gonzalez, Carlos Fernandez-Lago, MD, Maria Teresa Zudaire, MD, Mercedes Gironella, MD, Alfonso Soler, MD, David Valcarcel, MD, Jose Ángel Hernández-Rivas, MD, Carmen Marrero, MD, Montserrat Arnan, MD, Carmen Olivier, MD, Pau Abrisqueta, MD, Blanca Xicoy, MD, PhD, Josep Sarrá, MD, Benet Nomdedeu, MD, PhD, Eva González, MD, Jesus Martinez, MD, José González-Campos, MD, Cristina Encinas, MD, Almudena Laiglesia, MD, Cristina Fernández-Maqueda, MD, Isidro Jarque, MD, Christelle Ferra, MD, José Falantes, MD, Estrella Carrillo, MD, Cristina Muñoz, MD, J Feliú, MD, Marta Durán, Marina Marcos, Silvia López, Alfonso J Cruz-Jentoft, MD, PhD, Javier De La Rubia, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2979.
https://doi.org/10.1182/blood.V122.21.2979.2979
Published: 2013